Avinger (NASDAQ:AVGR) Trading Down 32.3%

Avinger Inc (NASDAQ:AVGR)’s share price dropped 32.3% during trading on Thursday . The stock traded as low as $1.06 and last traded at $1.13, approximately 1,944,120 shares traded hands during trading. An increase of 391% from the average daily volume of 395,596 shares. The stock had previously closed at $1.67.

AVGR has been the topic of several recent research reports. Zacks Investment Research upgraded Avinger from a “hold” rating to a “buy” rating and set a $2.00 price objective on the stock in a research report on Tuesday, August 6th. ValuEngine upgraded Avinger from a “hold” rating to a “buy” rating in a research report on Thursday, August 1st.

The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.17 and a current ratio of 1.45. The stock has a market capitalization of $10.73 million, a P/E ratio of -0.03 and a beta of 1.44. The firm has a 50-day moving average price of $2.13 and a 200 day moving average price of $1.13.

Avinger (NASDAQ:AVGR) last announced its quarterly earnings data on Wednesday, July 31st. The medical device company reported ($0.87) EPS for the quarter, beating the consensus estimate of ($0.90) by $0.03. The firm had revenue of $2.32 million for the quarter. Avinger had a negative return on equity of 230.13% and a negative net margin of 258.12%. On average, equities analysts anticipate that Avinger Inc will post -2.61 earnings per share for the current fiscal year.

An institutional investor recently bought a new position in Avinger stock. Spark Investment Management LLC bought a new stake in shares of Avinger Inc (NASDAQ:AVGR) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 103,043 shares of the medical device company’s stock, valued at approximately $98,000. Spark Investment Management LLC owned 0.21% of Avinger at the end of the most recent reporting period. 14.30% of the stock is currently owned by institutional investors.

Avinger Company Profile (NASDAQ:AVGR)

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

Recommended Story: What Factors Can Affect Return on Equity?

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.